Form 4: Inspire Medical Systems' Chief Technology Officer Sells Shares
SEC Form 4 Filing
John Rondoni, Chief Technology Officer of Inspire Medical Systems, sold 58 shares of common stock on January 7, 2025, at a price of $215 per share.
Summary
- John Rondoni, the Chief Technology Officer of Inspire Medical Systems, sold 58 shares of common stock on January 7, 2025.
- The sale was executed at a price of $215 per share.
- Following the transaction, Rondoni directly owns 11,322 shares of Inspire Medical Systems.
- The transaction was made pursuant to a Rule 10b5-1 trading plan dated May 23, 2024.
- Rondoni also acquired 32 shares under the Issuer's 2018 Employee Stock Purchase Plan since November 5, 2024.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a routine transaction. The sale of shares by an executive doesn't necessarily indicate a negative outlook, especially when conducted under a pre-arranged trading plan.
Industry Context
This filing is a routine disclosure of insider trading activity. It's common for executives to have pre-arranged trading plans to sell shares over time.
Stakeholder Impact
- The impact on stakeholders is likely minimal, as this is a small transaction by an individual executive.
Key Dates
| Date | Description |
|---|---|
| May 23, 2024 | Date of Rule 10b5-1 trading plan |
| November 5, 2024 | Date of Reporting Person's previous Form 4 |
| January 7, 2025 | Date of transaction (share sale) |
| January 10, 2025 | Date of signature on the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.